SCHEMBL6092353

SCHEMBL6092353

O=C(O)c1c(-c2ccccc2)c2cc(-c3ccc(Cl)cc3)ccc2n1Cc1cc(F)cc(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.56
PTGES2 Q9H7Z7 6/20 0.50
PTGES O14684 3/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
EDNRB P24530 2/20 0.49
EDNRA P25101 2/20 0.49
CYP3A4 P08684 1/20 0.49
MAPT P10636 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
ALOX12 P18054 1/20 0.49
PPARG P37231 1/20 0.49
RECQL P46063 1/20 0.49
BLM P54132 1/20 0.49
HSD17B10 Q99714 1/20 0.49
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6091085 0.88 PTGES2 (0.57) SERPINE1PTGES2PTGESMEN1KMT2A
SCHEMBL6093339 0.87 SERPINE1 (0.61) SERPINE1PTGES2PTGESMEN1KMT2A
SCHEMBL6091644 0.79 PTGES (0.51) SERPINE1PTGESEDNRBEDNRAMAPT
SCHEMBL14117729 0.79 SERPINE1 (0.56) SERPINE1MEN1KMT2AEDNRBEDNRA
SCHEMBL6091701 0.78 SERPINE1 (0.49) SERPINE1PTGES2PTGESEDNRBEDNRA
SCHEMBL2806758 0.77 SERPINE1 (0.63) SERPINE1EDNRBEDNRAPPARGPOLB
SCHEMBL6093097 0.77 SERPINE1 (0.51) SERPINE1PTGES2PTGESPPARGTBXAS1
SCHEMBL4980145 0.76 SERPINE1 (0.81) SERPINE1MEN1KMT2AEDNRBEDNRA
SCHEMBL21465578 0.76 PTGES2 (0.53) SERPINE1PTGES2PTGESMEN1KMT2A
SCHEMBL5172732 0.76 SERPINE1 (0.60) SERPINE1MEN1KMT2AEDNRBEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 SERPINE1 508/4885PTGES2 6/4885PTGES 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.